Cartesian Therapeutics (RNAC) FCF Margin Growth (1y) (2016 - 2026)
Cartesian Therapeutics (RNAC) FCF Margin Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | - |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn | 1,187.00 |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | 2,593.00 |
| 10 | Cartesian Therapeutics | 214.57 Mn | 214.57 Mn | - | -2.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.62 Mn |
| Dec 31, 2025 | -332,652.00 |
| Mar 31, 2025 | -192,590.00 |
| Dec 31, 2024 | 117,446.00 |
| Jun 30, 2024 | 13,695.00 |
| Mar 31, 2024 | -12,275.00 |
| Dec 31, 2023 | -20,563.00 |
| Sep 30, 2023 | -16,279.00 |
| Jun 30, 2023 | -15,512.00 |
| Mar 31, 2023 | -11,464.00 |
| Dec 31, 2022 | 3,182.00 |
| Sep 30, 2022 | 6,329.00 |
| Jun 30, 2022 | 205.00 |
| Mar 31, 2022 | 7,486.00 |
| Dec 31, 2021 | -5,319.00 |
| Sep 30, 2021 | -144,793.00 |
| Dec 31, 2020 | 13,789.00 |
| Dec 31, 2019 | 117,730.00 |
| Dec 31, 2018 | 7.40 Mn |
| Dec 31, 2017 | -7.54 Mn |